Back to Journals » Clinical Ophthalmology » Volume 13

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
6,178 | Dovepress* | 4,475 | 822+ | 1,751 | 5,297 |
PubMed Central* | 0 | 881 | 190 | 881 | |
Totals | 4,475 | 1,703 | 1,941 | 6,178 | |
*Since 12 February 2019 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar